| 21.2099 -0.136 (-0.64%) | 10-23 13:26 | |||||||||||||
|
|
| Short term | ||||
| Mid term | |
|||
| Targets | 6-month : | 24.99 | 1-year : | 29.19 |
| Resists | First : | 21.39 | Second : | 24.99 |
| Pivot price | 20.95 |
|||
| Supports | First : | 20.83 | Second : | 20.48 |
| MAs | MA(5) : | 21.26 |
MA(20) : | 20.88 |
| MA(100) : | 20.51 |
MA(250) : | 0 | |
| MACD | MACD : | 0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 88.3 |
D(3) : | 89.8 |
| RSI | RSI(14): 58.4 |
|||
| 52-week | High : | 22.56 | Low : | 19.45 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ MHIP ] has closed below upper band by 28.1%. Bollinger Bands are 50.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 21.26 - 21.36 | 21.36 - 21.45 |
| Low: | 20.89 - 21.04 | 21.04 - 21.16 |
| Close: | 21.01 - 21.23 | 21.23 - 21.4 |
The Milliman Healthcare Inflation Plus ETF (MHIP) is designed to shield and enhance investors' purchasing power against the backdrop of escalating medical expenditures. This is accomplished by leveraging proprietary actuarial data and sophisticated quantitative modeling. The fund’s analytical framework relies on Milliman's extensive database of actual healthcare claims, encompassing approximately 35 million insured individuals, to project future healthcare inflation through the examination of medical and pharmacy cost trajectories. Its investment portfolio encompasses both equity and fixed income securities spanning the entire healthcare supply chain, augmented by various inflation-hedging instruments such as commodities, Treasury Inflation-Protected Securities (TIPS), and conventional Treasury bonds. Typically, the MHIP portfolio undergoes monthly rebalancing, guided by a quantitative model that dynamically adjusts to shifts in US healthcare cost inflation. Specifically, the strategy increases its exposure to equities and commodities during periods of elevated inflation, conversely pivoting towards debt instruments when inflation levels are lower. The fund's holdings may further include derivative products like swaps, options, and futures contracts, as well as exchange-traded funds (ETFs).
Sun, 12 Jul 2026
MHIP - Milliman Healthcare Inflation Plus ETF Forecast, Target Price - Finviz
Wed, 10 Jun 2026
Watch: Captives offered hedge against healthcare inflation - Royal Gazette | Bermuda
Wed, 06 May 2026
ETF Prime: New Launches Surge Past 370 in 2026 - ETF Trends
Sun, 26 Apr 2026
Milliman Healthcare ETFs Target Rising Costs - 401k Specialist
Wed, 22 Apr 2026
If You Can't Beat Health Care Cost Increases ... Hedge Them? - ThinkAdvisor
Tue, 21 Apr 2026
Milliman Launches Healthcare Inflation ETFs (MHIG & MHIP) to Hedge the Rising Cost of U.S. Healthcare - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management - Bonds
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |